Britain Backs GSK’s Gene Therapy for ‘Bubble Boy’ Syndrome – New York Times
|
Britain Backs GSK’s Gene Therapy for ‘Bubble Boy’ Syndrome
New York Times Britain’s National Institute for Health and Care Excellence (NICE) said in draft guidance published on Friday that Strimvelis gene therapy used against adenosine deaminase deficiency, or ADA-SCID, improves overall survival compared with standard stem … |
Reuters |
Britain backs GSK’s gene therapy for ‘bubble boy’ syndrome
Reuters Britain’s National Institute for Health and Care Excellence (NICE) said in draft guidance published on Friday that Strimvelis gene therapy used against adenosine deaminase deficiency, or ADA-SCID, improves overall survival compared with standard stem … NHS to fund gene therapy for ‘bubble babies’ – The TelegraphTelegraph.co.uk NICE approves gene therapy for rare ‘bubble baby syndrome’NICE NICE nod for GSK’s ‘bubble baby syndrome’ gene therapyPharmaTimes The Times all 8 news articles » |
Telegraph.co.uk |
NHS to fund gene therapy for ‘bubble babies’
Telegraph.co.uk THE NHS will fund gene therapy for the first time, with a £500,000 treatment for “bubble baby syndrome”. Three babies are born each year with an immune defiency condition which leave them at constant risk of developing life-threatening infections. |
Gulf Times |
Stem cell infusions ‘improved health in frail elderly’
Gulf Times But as scientists work to unlock the mysteries of why some 80-year-olds must live in nursing homes while others play tennis every week, researchers with the University of Miami’s Interdisciplinary Stem Cell Institute said they found the beginnings of … |